Heron Therapeutics (HRTX) Other Gross PP&E Adjustments (2016 - 2025)
Heron Therapeutics (HRTX) has disclosed Other Gross PP&E Adjustments for 12 consecutive years, with $20.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 5.11% year-over-year to $20.9 million, compared with a TTM value of $20.9 million through Dec 2025, down 5.11%, and an annual FY2025 reading of $20.9 million, down 5.11% over the prior year.
- Other Gross PP&E Adjustments was $20.9 million for Q4 2025 at Heron Therapeutics, up from -$708000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $22.0 million in Q4 2024 and bottomed at -$15.6 million in Q1 2021.
- Average Other Gross PP&E Adjustments over 5 years is -$1.3 million, with a median of -$4.5 million recorded in 2024.
- The sharpest move saw Other Gross PP&E Adjustments soared 4036.7% in 2021, then plummeted 47.62% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at $8.6 million in 2021, then surged by 123.4% to $19.2 million in 2022, then tumbled by 47.62% to $10.0 million in 2023, then surged by 119.06% to $22.0 million in 2024, then fell by 5.11% to $20.9 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for HRTX at $20.9 million in Q4 2025, -$708000.0 in Q3 2025, and -$1.4 million in Q2 2025.